{"data":{"id":"10.6084/m9.figshare.1585000","type":"dois","attributes":{"doi":"10.6084/m9.figshare.1585000","prefix":"10.6084","suffix":"m9.figshare.1585000","identifiers":[],"alternateIdentifiers":[],"creators":[{"name":"Daniels, Johnny","nameType":"Personal","givenName":"Johnny","familyName":"Daniels","affiliation":[],"nameIdentifiers":[]},{"name":"Khogali, Mohammed","nameType":"Personal","givenName":"Mohammed","familyName":"Khogali","affiliation":[],"nameIdentifiers":[]},{"name":"Mohr, Erika","nameType":"Personal","givenName":"Erika","familyName":"Mohr","affiliation":[],"nameIdentifiers":[]},{"name":"Cox, Vivian","nameType":"Personal","givenName":"Vivian","familyName":"Cox","affiliation":[],"nameIdentifiers":[]},{"name":"Sizulu Moyo","affiliation":[],"nameIdentifiers":[]},{"name":"Edginton, Mary","nameType":"Personal","givenName":"Mary","familyName":"Edginton","affiliation":[],"nameIdentifiers":[]},{"name":"Hinderaker, Sven G","nameType":"Personal","givenName":"Sven G","familyName":"Hinderaker","affiliation":[],"nameIdentifiers":[]},{"name":"Meintjes, Graeme","nameType":"Personal","givenName":"Graeme","familyName":"Meintjes","affiliation":[],"nameIdentifiers":[]},{"name":"Hughes, Jennifer","nameType":"Personal","givenName":"Jennifer","familyName":"Hughes","affiliation":[],"nameIdentifiers":[]},{"name":"Azevedo, Virginia De","nameType":"Personal","givenName":"Virginia De","familyName":"Azevedo","affiliation":[],"nameIdentifiers":[]},{"name":"Cutsem, Gilles Van","nameType":"Personal","givenName":"Gilles Van","familyName":"Cutsem","affiliation":[],"nameIdentifiers":[]},{"name":"Cox, Helen S","nameType":"Personal","givenName":"Helen S","familyName":"Cox","affiliation":[],"nameIdentifiers":[]}],"titles":[{"title":"Time to ART initiation among patients treated for rifampicin-resistant tuberculosis in Khayelitsha, South Africa: impact on mortality and treatment success"}],"publisher":"figshare","container":{},"publicationYear":2015,"subjects":[{"subject":"110309 Infectious Diseases","subjectScheme":"FOR"},{"subject":"FOS: Health sciences","schemeUri":"http://www.oecd.org/science/inno/38235147.pdf","subjectScheme":"Fields of Science and Technology (FOS)"},{"subject":"FOS: Health sciences","subjectScheme":"Fields of Science and Technology (FOS)"}],"contributors":[],"dates":[{"date":"2015-10-26","dateType":"Created"},{"date":"2015-10-26","dateType":"Updated"},{"date":"2015","dateType":"Issued"}],"language":null,"types":{"ris":"DATA","bibtex":"misc","citeproc":"dataset","schemaOrg":"Dataset","resourceType":"Dataset","resourceTypeGeneral":"Dataset"},"relatedIdentifiers":[],"relatedItems":[],"sizes":["39938 Bytes"],"formats":[],"version":null,"rightsList":[{"rights":"Creative Commons Attribution 4.0 International","rightsUri":"https://creativecommons.org/licenses/by/4.0/legalcode","schemeUri":"https://spdx.org/licenses/","rightsIdentifier":"cc-by-4.0","rightsIdentifierScheme":"SPDX"}],"descriptions":[{"description":"We conducted a retrospective cohort study of HIV-infected RR-TB patients not on ART at initiation of second-line anti-tuberculosis treatment. Our outcome measurements were time to ART initiation and RR-TB treatment outcomes","descriptionType":"Abstract"}],"geoLocations":[],"fundingReferences":[],"xml":"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","url":"https://figshare.com/articles/dataset/Time_to_ART_initiation_among_patients_treated_for_rifampicin_resistant_tuberculosis_in_Khayelitsha_South_Africa_impact_on_mortality_and_treatment_success/1585000","contentUrl":null,"metadataVersion":1,"schemaVersion":"http://datacite.org/schema/kernel-4","source":"mds","isActive":true,"state":"findable","reason":null,"viewCount":0,"viewsOverTime":[],"downloadCount":0,"downloadsOverTime":[],"referenceCount":0,"citationCount":0,"citationsOverTime":[],"partCount":0,"partOfCount":0,"versionCount":0,"versionOfCount":0,"created":"2015-10-26T10:40:51.000Z","registered":"2015-10-26T10:40:52.000Z","published":"2015","updated":"2020-09-04T14:49:34.000Z"},"relationships":{"client":{"data":{"id":"figshare.ars","type":"clients"}},"provider":{"data":{"id":"otjm","type":"providers"}},"media":{"data":{"id":"10.6084/m9.figshare.1585000","type":"media"}},"references":{"data":[]},"citations":{"data":[]},"parts":{"data":[]},"partOf":{"data":[]},"versions":{"data":[]},"versionOf":{"data":[]}}}}